货号:GS40077
Bepranemab is an investigational, humanized monoclonal antibody designed to target Tau protein. It specifically binds to the central region of the Tau protein, aiming to prevent its pathological cell-to-cell propagation and aggregation in the brain. By targeting this region, it is intended to inhibit the spread of Tau pathology, which is a key driver of neurodegeneration in diseases like Alzheimer's disease (AD) and progressive supranuclear palsy (PSP). It is currently in clinical development (Phase II) for the treatment of these Tauopathies.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
迈思生物